Assemblywoman Lisa Calderon introduced a resolution on the floor of the California State Assembly recognizing March as Sleep Apnea Awareness Month in California. The resolution formally acknowledges obstructive sleep apnea (OSA) as a serious and underdiagnosed public health issue with consequences for individual health, workforce safety, and public safety. “Sleep […]
Industry News
Acquisitions | Awards | Events | News | Partnerships
Panthera Sleep Announces Research Grant Winner
Panthera Dental is proud to announce Dr. Chidsanu Changsiripun (PI), D.D.S., M.Sc., Ph.D., from Chulalongkorn University, Thailand, as the recipient of the 2025 Panthera Sleep Research Grant. Dr. Changsiripun’s research proposal, Deep Learning-Assisted vs. Conventional Subjective Titration in MAD Therapy for OSA, was selected through a rigorous anonymous peer-review process […]
British Columbia Adopts Permanent Daylight Saving Time
British Columbia has adopted permanent year-round daylight saving time (DST) to improve people’s overall health, reduce disruptions for families, simplify scheduling, and provide an extra hour of evening light during the winter months. The transition to one year-round time zone began on Sunday, March 8, 2026, when clocks moved ahead […]
Bleep LLC appoints Thomas P. Beckley to Board of Directors
Bleep LLC, maker of the Eclipse™ mask-less CPAP solution, announced technologist and electronics industry veteran Tom Beckley has joined the Company’s Board of Directors. “As a successful technology entrepreneur with extensive knowledge of AI, software and advanced electro-mechanical systems, I’m very pleased Tom has joined Bleep’s Board of Directors,” said […]
Nexalin’s HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Insomnia Market
Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]
Jamison Spencer, DDS, MS, Joins Sleep Education Partners
Jamison Spencer, DDS, MS, will serve as a contributing author for Sleepedu. His responsibilities will be primarily to author dental-sleep-related courses. Dr. Spencer has a passion for bringing practicing sleep dentists and physicians together to foster understanding and mutual respect between the two groups. His courses will discuss those relationships […]
Clear Chronic Care Expands Nationally, Enters Sleep Medicine Market
Clear Chronic Care announced continued national expansion of its Medicare-focused Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform, reinforcing its position as a long-term infrastructure partner to physician practices navigating value-based reimbursement. The company also announced strategic expansion into sleep medicine, where chronic oversight and adherence management are […]
ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine
ProSomnus Sleep Technologies announced a strategic investment from Catalio Capital Management, L.P. to accelerate the global expansion of its technology-enabled sleep health platform. Under the agreement, Catalio, a premier healthcare-focused investment firm, has committed up to $38 million to advance development of next-generation remote patient monitoring (RPM) and proprietary sleep […]
In November, the Percentage of Patients with a Telehealth Claim Increased Nationally and Regionally
The percentage of patients with a telehealth claim increased nationally and in every region in November 2025, according to FAIR Health’s Monthly Telehealth Regional Tracker. Nationally, that percentage increased from 14.5 percent in October to 15.0 percent in November, a 3.6 percent rise. The largest increase was in the Midwest, at 5.1 […]
Alkermes Completes Acquisition of Avadel, Accelerating Entry Into Sleep Medicine Market
Alkermes plc and Avadel Pharmaceuticals plc, announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep […]













